Literature DB >> 8402598

Germ-line p53 mutation is uncommon in patients with triple primary cancers.

M Shiseki1, R Nishikawa, H Yamamoto, A Ochiai, H Sugimura, N Shitara, Y Sameshima, H Mizoguchi, T Sugimura, J Yokota.   

Abstract

We examined five patients with multiple primary cancers who had a history of three different types of primary cancers for germ-line p53 mutations. The germ-line p53 mutation was detected in a patient who conformed to the Li-Fraumeni syndrome, but not in the other four patients. The diagnosis of these four patients did not fall in the category of Li-Fraumeni syndrome. This result indicates that germ-line p53 mutations are uncommon even in patients with triple primary cancers.

Entities:  

Mesh:

Year:  1993        PMID: 8402598     DOI: 10.1016/0304-3835(93)90187-e

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  8 in total

Review 1.  Breast Cancer and Multiple Primary Malignant Tumors: Case Report and Review of the Literature.

Authors:  Alessandro De Luca; Federico Frusone; Massimo Vergine; Rosario Cocchiara; Giuseppe La Torre; Laura Ballesio; Massimo Monti; Maria Ida Amabile
Journal:  In Vivo       Date:  2019 Jul-Aug       Impact factor: 2.155

2.  A TP53 founder mutation, p.R337H, is associated with phyllodes breast tumors in Brazil.

Authors:  Juliana Giacomazzi; Patricia Koehler-Santos; Edenir Inez Palmero; Marcia S Graudenz; Luis Fernando Rivero; Eduardo Lima; Antonio Carlos Kruel Pütten; Pierre Hainaut; Suzi Alves Camey; Rodrigo Depieri Michelli; Cristovam Scapulatempo Neto; Mariana Fitarelli-Kiehl; Geraldo Geyer; Luise Meurer; Ana Geiger; Monica Blaya Azevedo; Vinicius Duval da Silva; Patricia Ashton-Prolla
Journal:  Virchows Arch       Date:  2013-06-21       Impact factor: 4.064

Review 3.  Tumors associated with p53 germline mutations: a synopsis of 91 families.

Authors:  P Kleihues; B Schäuble; A zur Hausen; J Estève; H Ohgaki
Journal:  Am J Pathol       Date:  1997-01       Impact factor: 4.307

Review 4.  Li-Fraumeni syndrome--a molecular and clinical review.

Authors:  J M Varley; D G Evans; J M Birch
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

5.  A clinical and genetic analysis of multiple primary cancer referrals to genetics services.

Authors:  James Whitworth; Jon Hoffman; Cyril Chapman; Kai Ren Ong; Fiona Lalloo; D Gareth Evans; Eamonn R Maher
Journal:  Eur J Hum Genet       Date:  2014-09-24       Impact factor: 4.246

6.  A novel combination of multiple primary carcinomas: urinary bladder transitional cell carcinoma, prostate adenocarcinoma and small cell lung carcinoma--report of a case and review of the literature.

Authors:  Anastassios V Koutsopoulos; Konstantina I Dambaki; George Datseris; Elpida Giannikaki; Marios Froudarakis; Efstathios Stathopoulos
Journal:  World J Surg Oncol       Date:  2005-07-26       Impact factor: 2.754

7.  Absence of germline CHK2 mutations in familial gastric cancer.

Authors:  K Kimura; K Shinmura; K Yoshimura; K Shimizu; H Katai; Y Beppu; H Moriya; J Yokota
Journal:  Jpn J Cancer Res       Date:  2000-09

8.  Characteristics of Li-Fraumeni Syndrome in Japan; A Review Study by the Special Committee of JSHT.

Authors:  Michinori Funato; Yukiko Tsunematsu; Fumito Yamazaki; Chieko Tamura; Tadashi Kumamoto; Masatoshi Takagi; Shunsuke Kato; Haruhiko Sugimura; Kazuo Tamura
Journal:  Cancer Sci       Date:  2021-05-01       Impact factor: 6.716

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.